Publicaciones en colaboración con investigadores/as de Universidade de Lisboa (5)

2022

  1. Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance

    Annals of the rheumatic diseases, Vol. 81, Núm. 7, pp. 970-978

  2. Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study

    The Lancet Rheumatology, Vol. 4, Núm. 9, pp. e603-e613

2021

  1. Association between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death among Patients with Immune-Mediated Inflammatory Disease and COVID-19

    JAMA Network Open

2015

  1. The EULAR Study Group for Registers and Observational Drug Studies: Comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers

    Rheumatology (United Kingdom), Vol. 54, Núm. 6, pp. 1074-1079

2010

  1. EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology

    Annals of the Rheumatic Diseases, Vol. 69, Núm. 9, pp. 1596-1602